N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheumatica

Sponsor: Washington University School of Medicine • ClinicalTrials.gov ID: NCT07749547

Registry updated: 2026-10-07
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Polymyalgia rheumatica (PMR) is a condition that causes joint pain and stiffness, making it hard for people to do everyday tasks. Movement pattern training is a special, personalized rehabilitation program that aims to reduce pain by improving how people move during their daily activities. The investigators plan to test if it's possible to conduct a detailed study to find out how effective Movement pattern training is for people with PMR. The investigators will look at whether it helps them perform activities they want to do, reduce their use of certain medications, and strengthen their muscles. The investigators will also gather feedback from patients about their experience with Movement pattern training. This study will help us understand if carrying out a larger study on Movement pattern training's effectiveness is practical.

Interventions

  • Movement Pattern Training (MoveTrain) (Behavioral)
    6 individualized treatment sessions over 10 weeks * Motivational interviewing to determine personal goals and strengthen motivation and commitment to change * Activity-specific training to practice modified motion during patient-specific tasks, defined as activities reported by each patient as pain-provoking * Home exercise program 3 times/week consisting of activities or exercises assigned in the supervised sessions * Patient's independence and adherence in performing home exercise program will be documented * Patients are encouraged to use modified motion during daily and physical activities * Based on patient performance, activity difficulty is progressed by increasing repetitions performed or increasing load or speed
  • Usual Care (Other)
    * Basic education about polymyalgia rheumatica, benefits of physical activity * Patients will be encouraged to participate in physical activity as tolerated * Medication as prescribed by their physician

Eligibility criteria

Inclusion Criteria: * Patient reports a diagnosis or flare of polymyalgia rheumatica (PMR) \< 5 months before the screening contact * Diagnosis or flare of PMR according to the European League against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria as follows (must satisfy all criteria)10: * Age ≥50 years at time of diagnosis * Presence of bilateral shoulder pain * Elevated acute phase reactants C-reactive protein (CRP) \>10 milligram/Liter and/or Erythrocyte Sedimentation Rate (ESR) \>30 millimeters/hour\* * A score ≥4 at the time of diagnosis based on the following (without ultrasound): * Duration of morning stiffness \>45 minutes: 2 points * Hip pain or limited range of motion: 1 point * Seronegative for rheumatoid factor and anti-cyclic citrullinated peptide: 2 points * Absence of other joint involvement: 1 point * Initiated pharmacological treatment * Able to give informed consent * Physician's clearance to participate in physical activity Exclusion Criteria: * Diagnosis of fibromyalgia, neuropathic muscular disease, complex regional pain syndrome, or small fiber neuropathy * planned major surgical procedure during the study * Current active uncontrolled infection

Conditions

Polymyalgia Rheumatica (PMR)

Locations

  • Washington University School of Medicine, Program in Physical Therapy — St Louis, Missouri, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record